SCHEMBL144946

SCHEMBL144946

CCCCC1CC[CH]CCC1

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.61
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
SIGMAR1 Q99720 3/20 0.34
MAPT P10636 1/20 0.34
NOS1 P29475 2/20 0.33
NOS2 P35228 2/20 0.33
POLB P06746 1/20 0.33
HPGD P15428 1/20 0.33
HRH3 Q9Y5N1 1/20 0.31
TLR7 Q9NYK1 1/20 0.30
BCHE P06276 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10996093 0.94 CYP1A2 (0.65) CYP1A2LMNAMAPK1HTTSIGMAR1
SCHEMBL3031906 0.94 CYP1A2 (0.54) CYP1A2LMNAMAPK1HTTSIGMAR1
SCHEMBL455412 0.92 CYP1A2 (0.52) CYP1A2LMNAMAPK1HTTSIGMAR1
SCHEMBL11333473 0.92 CYP1A2 (0.69) CYP1A2LMNAMAPK1HTTSIGMAR1
SCHEMBL42267 0.91 CYP1A2 (0.58) CYP1A2LMNAMAPK1HTTMAPT
SCHEMBL27288023 0.89 CYP1A2 (0.56) CYP1A2LMNAMAPK1HTTMAPT
SCHEMBL21409484 0.88 CYP1A2 (0.57) CYP1A2LMNAMAPK1HTTSIGMAR1
SCHEMBL5354505 0.88 CYP1A2 (0.56) CYP1A2LMNAMAPK1HTTSIGMAR1
SCHEMBL9474398 0.88 CYP1A2 (0.56) CYP1A2LMNAMAPK1HTTSIGMAR1
SCHEMBL27724374 0.88 CYP1A2 (0.56) CYP1A2LMNAMAPK1HTTSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 367 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379577-B1 CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES SOLUTIA INC (US) 2004-08-25 EP claimed
US-6737159-B2 Controlling solar radiation in safety glass laminates SOLUTIA, INC. 2004-05-18 US claimed
EP-1379577-A1 CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES Solutia Inc. (US) 2004-01-14 EP claimed
US-20020182422-A1 Controlling solar radiation in safety glass laminates SOLUTIA INC. 2002-12-05 US claimed
WO-2002077081-A1 CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES SOLUTIA, INC. (US) 2002-10-03 WO claimed
CN-115175967-B Ionic liquids for stabilizing viscosity of silicate-based coatings 巴斯夫欧洲公司 2024-06-14 CN disclosed
CN-113330096-B Use of substituted or unsubstituted polycyclic aromatic compounds for high resolution microscopy 马克斯·普朗克索赔科学公司 2024-05-31 CN disclosed
US-11958796-B2 Hydrophilic and particularly water soluble DBOV-derivatives MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2024-04-16 US disclosed
CN-112839922-B Hydrophilic and in particular water-soluble DBOV derivatives 马克斯·普朗克索赔科学公司 2024-04-02 CN disclosed
EP-3183250-B1 PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL CLAP CO LTD (KR) 2023-10-04 EP disclosed
US-20230303608-A1 DITHIOLENE METAL COMPLEXES BASF SCHWEIZ AG (CH) 2023-09-28 US disclosed
EP-4182395-A1 DITHIOLENE METAL COMPLEXES BASF SE (DE) 2023-05-24 EP disclosed
US-20040068114-A1 Rylene derivatives BASF AKTIENGESELLSCHAFT (DE) 2004-04-08 US disclosed
US-20040049030-A1 Tert alkylphenoxy substituted polycyclic compounds BASF SE (DE) 2004-03-11 US disclosed
EP-1379577-A1 CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES Solutia Inc. (US) 2004-01-14 EP disclosed
US-20020182422-A1 Controlling solar radiation in safety glass laminates SOLUTIA INC. 2002-12-05 US disclosed
US-6486319-B1 Thermochromic rylene dyes BASF AKTIENGESELLSCHAFT (DE) 2002-11-26 US disclosed
WO-2002077081-A1 CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES SOLUTIA, INC. (US) 2002-10-03 WO disclosed
EP-1206456-A1 THERMOCHROMIC RYLENE DYES BASF AKTIENGESELLSCHAFT (DE) 2002-05-22 EP disclosed
WO-2001016109-A1 THERMOCHROMIC RYLENE DYES BASF AKTIENGESELLSCHAFT (DE) 2001-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303608-A1 DITHIOLENE METAL COMPLEXES TST, C1S, F12 CYP1A2 1684/4885LMNA 3797/4885MAPK1 2708/4885
US-11958796-B2 Hydrophilic and particularly water soluble DBOV-derivatives NR1H4, HDGF, ABHD16A CYP1A2 414/4885LMNA 4504/4885MAPK1 4342/4885
US-20040049030-A1 Tert alkylphenoxy substituted polycyclic compounds NR3C1, NR1H4, NR5A1 CYP1A2 407/4885LMNA 2496/4885MAPK1 1715/4885
US-20040068114-A1 Rylene derivatives RER1, MALT1, GHSR CYP1A2 192/4885LMNA 4026/4885MAPK1 512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.